Treatment of Double-Refractory Chronic Lymphocytic Leukemia—An Unmet Clinical Need
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25031589 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Przemysław Zygmunciak und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Institute of Hematology and Transfusion Medicine, 02-776 Warsaw, Poland. Hauptthemen laut MEDLINE: Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Recent years have seen significant improvement in chronic lymphocytic leukemia (CLL) management. Targeting B-cell lymphoma (BCL-2) and Bruton’s kinase (BTK) have become the main strategies to restrain CLL activity. These agents are generally well tolerated, but the discontinuation of these therapies happens due to resistance, adverse effects, and Richter’s transformation. A growing population of patients who have previously used both BTK inhibitors and BCL2 suffer from the constriction of the following regimens. This review explores the resistance mechanisms for both ibrutinib and venetoclax. Moreover, we present innovative approaches evaluated for treating double-refractory CLL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Institute of Hematology and Transfusion Medicine, 02-776 Warsaw, Poland.
- Department of Hematology, Medical University of Lodz, 93-510 Lodz, Poland.
- Department of General Hematology, Copernicus Memorial Hospital, 93-510 Lodz, Poland.
ORCID-Profile: Tadeusz Robak, Bartosz Puła
Zitieren
APA
Zygmunciak, P., Robak, T., & Puła, B. (2024). Treatment of Double-Refractory Chronic Lymphocytic Leukemia—An Unmet Clinical Need. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25031589
Vancouver
Zygmunciak P, Robak T, Puła B. Treatment of Double-Refractory Chronic Lymphocytic Leukemia—An Unmet Clinical Need. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25031589
BibTeX
@article{Zygmunciak2024,
author = {Zygmunciak, Przemysław and Robak, Tadeusz and Puła, Bartosz},
title = {Treatment of Double-Refractory Chronic Lymphocytic Leukemia—An Unmet Clinical Need},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25031589}
}
EUVIMED